{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:07:18Z","timestamp":1791284838917,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274297"],"award-info":[{"award-number":["82274297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274257"],"award-info":[{"award-number":["82274257"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20221246"],"award-info":[{"award-number":["BK20221246"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SKYD2023153"],"award-info":[{"award-number":["SKYD2023153"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SKY2022200"],"award-info":[{"award-number":["SKY2022200"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SYW2025020"],"award-info":[{"award-number":["SYW2025020"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.phymed.2025.157680","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T15:17:47Z","timestamp":1765120667000},"page":"157680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Jianpi Jiedu formula modulates glutamine metabolism to inhibit colorectal cancer liver metastasis"],"prefix":"10.1016","volume":"150","author":[{"given":"Yicun","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhou","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2025.157680_bib0001","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejca.2018.10.009","article-title":"Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer: a systematic review and meta-analysis","volume":"106","author":"Baraniskin","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.phymed.2025.157680_bib0002","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMa"},{"key":"10.1016\/j.phymed.2025.157680_bib0003","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.2023.41.4_suppl.139","article-title":"A phase II single-arm study of the FGFR inhibitor pemigatinib in patients with metastatic colorectal cancer (mCRC) harboring FGF\/FGFR alterations","volume":"41","author":"Ciombor","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phymed.2025.157680_bib0004","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(22)00197-8","article-title":"Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study","volume":"23","author":"Diaz","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phymed.2025.157680_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217186","article-title":"YTHDF1 regulates GID8-mediated glutamine metabolism to promote colorectal cancer progression in m6A-dependent manner","volume":"601","author":"Han","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2025.157680_bib0006","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1111\/jcmm.15009","article-title":"Lobetyolin induces apoptosis of colon cancer cells by inhibiting glutamine metabolism","volume":"24","author":"He","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.phymed.2025.157680_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309094","article-title":"A PD-L1-targeting regulator for metabolic reprogramming to enhance glutamine inhibition-mediated synergistic antitumor metabolic and immune therapy","volume":"36","author":"Jin","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phymed.2025.157680_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154082","article-title":"Jianpi Jiedu Recipe inhibits colorectal cancer liver metastasis via regulating ITGBL1-rich extracellular vesicles mediated activation of cancer-associated fibroblasts","volume":"100","author":"Li","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.157680_bib0009","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12964-023-01449-x","article-title":"Glutamine addiction in tumor cell: oncogene regulation and clinical treatment","volume":"22","author":"Li","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.phymed.2025.157680_bib0010","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","article-title":"The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation","volume":"48","author":"Liu","year":"2020","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.phymed.2025.157680_bib0011","article-title":"JianPi JieDu recipe inhibits epithelial-to-mesenchymal transition in colorectal cancer through TGF-\u03b2\/smad mediated snail\/e-cadherin expression","volume":"2017","author":"Liu","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phymed.2025.157680_bib0012","article-title":"An injectable puerarin depot can potentiate chimeric antigen receptor natural killer cell immunotherapy against targeted solid tumors by reversing tumor immunosuppression","volume":"20","author":"Liu","year":"2024","journal-title":"Small."},{"key":"10.1016\/j.phymed.2025.157680_bib0013","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/cr.2017.107","article-title":"Twa1\/Gid8 is a \u03b2-catenin nuclear retention factor in Wnt signaling and colorectal tumorigenesis","volume":"27","author":"Lu","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.phymed.2025.157680_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6614574","article-title":"Salidroside suppresses the proliferation and migration of human lung cancer cells through AMPK-dependent NLRP3 inflammasome regulation","volume":"2021","author":"Ma","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"issue":"4","key":"10.1016\/j.phymed.2025.157680_bib0015","first-page":"59","article-title":"Animal models of colorectal cancer: from spontaneous to genetically engineered models and their applications","volume":"8","author":"Nascimento-Gon\u00e7alves","year":"2021","journal-title":"Vet. Sci."},{"key":"10.1016\/j.phymed.2025.157680_bib0016","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2016.01.048","article-title":"Animal models of colorectal cancer with liver metastasis","volume":"387","author":"Oh","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2025.157680_bib0017","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.phymed.2025.157680_bib0018","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41568-024-00752-0","article-title":"Cancer-induced systemic pre-conditioning of distant organs: building a niche for metastatic cells","volume":"24","author":"Rabas","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2025.157680_bib0019","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2025.157680_bib0020","first-page":"233","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2025.157680_bib0021","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.celrep.2016.09.045","article-title":"Addiction to coupling of the warburg effect with glutamine catabolism in cancer cells","volume":"17","author":"Smith","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.phymed.2025.157680_bib0022","first-page":"3505","article-title":"The glutamate\/aspartate transporter EAAT1 is crucial for T-cell acute lymphoblastic leukemia proliferation and survival","volume":"109","author":"Stanulovi\u0107","year":"2024","journal-title":"Haematologica."},{"key":"10.1016\/j.phymed.2025.157680_bib0023","article-title":"Traditional Chinese medicine and colorectal cancer: implications for drug discovery","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157680_bib0024","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cmet.2018.07.005","article-title":"A role for p53 in the adaptation to glutamine starvation through the expression of SLC1A3","volume":"28","author":"Tajan","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2025.157680_bib0025","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41591-022-02181-8","article-title":"Combined PD-1, BRAF and MEK inhibition in BRAF(V600E) colorectal cancer: a phase 2 trial","volume":"29","author":"Tian","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2025.157680_bib0026","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10585-015-9719-0","article-title":"Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases","volume":"32","author":"van der Geest","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.phymed.2025.157680_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113376","article-title":"The role of metabolic reprogramming in cancer metastasis and potential mechanism of traditional Chinese medicine intervention","volume":"153","author":"Wang","year":"2022","journal-title":"Biomed. PharmacOther."},{"issue":"9","key":"10.1016\/j.phymed.2025.157680_bib0028","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1016\/j.apsb.2022.03.014","article-title":"Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1\u03b1\/NF-\u03bab feedback pathway to inhibit liver fibrosis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2025.157680_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105728","article-title":"Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy","volume":"170","author":"Wang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2025.157680_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13046-023-02729-7","article-title":"Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2025.157680_bib0031","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2025.157680_bib0032","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends. Biochem. Sci."},{"key":"10.1016\/j.phymed.2025.157680_bib0033","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s43018-020-00160-x","article-title":"Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma","volume":"2","author":"Wu","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.phymed.2025.157680_bib0034","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41419-018-1291-5","article-title":"Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization","volume":"10","author":"Xiang","year":"2019","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2025.157680_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119769","article-title":"Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model","volume":"235","author":"Xu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.phymed.2025.157680_bib0036","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/0008-5472.CAN-24-0254","article-title":"Therapeutic targeting of the GLS1-c-myc positive feedback loop suppresses glutaminolysis and inhibits progression of head and Neck cancer","volume":"84","author":"Yang","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2025.157680_bib0037","article-title":"Therapeutic effect and mechanism of bushen-jianpi-jiedu decoction combined with chemotherapeutic drugs on postoperative colorectal cancer","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157680_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156907","article-title":"Astragaloside IV inhibits the growth of obesity-associated triple-negative breast cancer by activating FOXA1 transcription factor to regulate GAL3ST1-GalCer signaling and remodel sphingolipid metabolism","volume":"144","author":"Yang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.157680_bib0039","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.2147\/OTT.S235667","article-title":"Berberine inhibits growth of liver cancer cells by suppressing glutamine uptake","volume":"12","author":"Zhang","year":"2019","journal-title":"Onco Targets. Ther."},{"key":"10.1016\/j.phymed.2025.157680_bib0040","article-title":"Use of Jianpi Jiedu herbs in patients with advanced colorectal cancer: a systematic review and meta-analysis","volume":"2018","author":"Zhang","year":"2018","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"10.1016\/j.phymed.2025.157680_bib0041","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1142\/S0192415X21500385","article-title":"Colorectal cancer, gut microbiota and traditional chinese medicine: a systematic review","volume":"49","author":"Zhao","year":"2021","journal-title":"Am. J. Chin. Med."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325013157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325013157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:32:42Z","timestamp":1778776362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325013157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"alternative-id":["S0944711325013157"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157680","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Jianpi Jiedu formula modulates glutamine metabolism to inhibit colorectal cancer liver metastasis","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157680"}}